BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) to Give Keynote Address at International Gathering of Romanian Leaders


7/12/2012 9:11:17 AM

SAN DIEGO, CA--(Marketwire - July 12, 2012) - Medistem Inc. (PINKSHEETS: MEDS) announced today it has been chosen by the Romanian Cultural Association to give a keynote talk at its annual gathering in Hamilton, Canada.

The meeting, which is a week-long celebration of Romanian cultural and scientific accomplishments, has featured Romanian luminaries including former Romanian Prime Minister Victor Ciorbea, Minister of Romanian Culture and Art Ion Caramitru, and History of Religion Scholar Mircea Eliade as keynote speakers.

"We are proud of the work Dr. Thomas Ichim is performing in the area of adult stem cells, having led the company Medistem from discovering a new stem cell to clinical trials within the short span of 4 years," said Dumitru Rachitan, President of the Romanian Cultural Association. "Given that this is the only stem cell company that has received endorsement of the Orthodox Church, we are eager to hear how the company has circumvented ethical issues associated with stem cells, and reached its milestone of beginning to use stem cells in patients."

Medistem's CEO, Thomas Ichim, will present his work in Romanian, in a talk entitled "Endometrial Regenerative Cells: A Journey from Discovery to Patients."

"As a second-generation Romanian, I am proud to have been chosen by my scientific peers in Romania to present our work at this prestigious event," said Ichim. "We hope that these beginning interactions will lead to collaborations and possibly expansion of our clinical programs."

Currently Medistem has two ongoing clinical programs, in heart failure and critical limb ischemia, using its universal donor stem cell, the Endometrial Regenerative Cell.

Cautionary Statement
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of our securities. This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking information. Factors which may cause actual results to differ from our forward-looking statements are discussed in our Form 10-K for the year ended December 31, 2007 as filed with the Securities and Exchange Commission.


Contact:
Thomas Ichim
Chief Executive Officer
Medistem Inc.
9255 Towne Centre Drive
Suite 450
San Diego
CA 92122
858 349 3617
858 642 0027
www.medisteminc.com
twitter: @thomasichim

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES